'''For women with the most common type of breast cancer, a new way to analyze magnetic resonance images (MRI) data appears to reliably distinguish between patients who would need only hormonal treatment and those who also need chemotherapy, researchers from ...'
'''IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) (IMRIS or the Company) today announced that it has received a Health Canada medical device license for AccuTrack™ the Company's 3D imageguidance tool for use in IMRIS neurosurgery suites. AccuTrack™ represents a ...'